Podcasts about pharmaceutical

The Strange Murders of the Wealthiest Murder Victims in History. Who killed the Billionaire Pharmaceutical CEO Barry and Honey Sherman? Why were their bodies placed in odd positions? Was a hitman hired by a Pharmaceutical company? To watch the podcast on YouTube: ⁠⁠⁠⁠⁠https://bit.ly/TheoriesOfTheThirdKindYT⁠⁠⁠⁠⁠ - Get instant access to 200+ bonus Audio episodes - Sign up here: ⁠⁠⁠⁠⁠https://theoriesofthethirdkind.supercast.com⁠ To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

References NeuroMolecular Medicine2024. Volume 26,article 2.J of Neurochemistry 2018. V146, Issue4 August:416-428Rimsky-Korsikov. 1888. Scheherazade OP 35https://music.youtube.com/watch?v=zY4w4_W30aQ&si=9Q0bhwIdpY2aZ5yFAnderson, J. 1971 ".Your Move ". YEShttps://music.youtube.com/watch?v=WfgPEh2J9aI&si=QeKguSCVouRgjhR7

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, connects with Matt Rich, PwC's Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They discuss how companies can stay agile in the face of regulatory uncertainty, avoid preventable delays, and take practical steps to move programs forward with clarity.Discussion highlights:Ongoing restructuring at the FDA is creating uncertainty and delays in drug and device approvals, with wide-ranging impacts across the pharma, biotech and medtech landscape.While companies can't control the regulatory environment, they can focus on improving internal speed, efficiency, and submission quality to keep programs moving forwardAvoiding preventable missteps, or “foot faults,” in data, endpoints, and submission packages is critical to reducing review delays and regulatory pushbackDiversifying risk by pursuing parallel regulatory pathways in other regions such as Europe and Japan can help accelerate access and reduce dependency on a single agencyIn the absence of a clear playbook, companies should focus on what they can control by applying past lessons, staying disciplined, and collaborating across the industry to support more efficient FDA review processesSpeakers:Matt Rich, PwC's Pharmaceutical and Life Sciences R&D LeaderGlenn Hunzinger, Partner, Health Industries Leader, PwCLinked materials:Navigating the FDA disruption: 4 key actions for pharmaFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in as Glenn Hunzinger, PwC's Health Industries Leader and Roel van den Akker, PwC's Pharma and Life Sciences Deals Leader discuss the rapid rise of China's biotech industry and what it means for U.S. pharmaceutical companies. They discuss the evolving role of Chinese biotech in the global innovation landscape and share perspectives on how U.S. pharmaceutical companies can thoughtfully assess opportunities, manage cross-border complexities, and build effective partnering and diligence strategies.  Discussion highlights:China's biotech industry is growing fast and becoming a global player, with U.S. companies increasingly looking to partner with Chinese firms on cutting-edge scienceU.S. pharma leaders are encouraged to move beyond skepticism and stay curious by building relationships, learning from local innovation, and exploring new partnership opportunitiesSuccessfully partnering with Chinese biotech firms requires a careful and well-structured approach that accounts for global complexity, protects data and IP, and uses creative deal structures like new company formations to manage risk and stay flexibleU.S. companies need to be proactive in order to stay competitive by actively exploring global innovation, understanding the risks, and having a clear strategy to bring high-potential science to U.S. patientsSpeakers:Roel Van den Akker, Pharmaceutical and Life Sciences Deals Leader Glenn Hunzinger, Partner, Health Industries Leader, PwCLinked materials:China's rise as a biotech innovation hub: 4 key strategic questions for US biopharma executivesFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Join Charles River experts Sandy Kimber, Charlotte Cumper, and Claire Richards from our Portishead site for a discussion on what makes some viruses more contagious than others, how viruses can trick your immune system, and how vaccines can affect viral spread.

In this episode, I sit down with Shay Domangue, PA-C, whose career path took a bold and inspiring turn — from hospitalist PA/ internal medicine to building her own social media business in elder care to transitioning to marketing development in the pharmaceutical device industry. She's now the Gulf Coast Field Market Development Specialist in the Renal Denervation business unit for Medtronic and is also raising two little humans (with her husband's help).Shay shares what it was like to reach a breaking point in clinical medicine and how listening to that inner voice led her to explore something new. She didn't just walk away — she walked toward a more aligned, values-based life and career.We talk about the early days of entrepreneurship, the emotional and logistical challenges of building something from scratch, and the surprising role that networking played in her transition into the pharmaceutical industry.Shay opens up about redefining success, protecting her energy, and how work-life balance has become a non-negotiable in her new chapter. She also drops some hard-earned wisdom for clinicians who are feeling stuck or wondering what else is out there — especially if you've ever thought, “I can't do this for 20 more years.”This conversation is for you if you're craving purpose, dreaming of flexibility, or just want to hear from someone who's made a major pivot and lived to tell the tale.CONNECT WITH SHAY:Linkedin.com/in/shaydomangueShay's polypharmacy info on TikTok: @elder.care.hubHOPE'S BOOK:⁠⁠Healing Clinician Burnout, How to Revive Your Life and Career ⁠⁠(available in ebook and paperback)CONNECT AND SIGN UP FOR COACHING:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's Website: www.coachhopecook.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's IG @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's FB @hopeallencook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's LinkedIn: hope-cook-56041283/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's YouTube @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email: hope.cook@gmail.comLove y'all, and remember: There's always hope!

I briefly discuss how the pharmaceutical collapse and price reduction, along with global deals and alliances that are being made are all a part of the plan.  I also discuss child exploitation, the role of schools; and more jab revelations along with the elimination of Fluoride in Florida drinking water.   Book Websites: https://www.moneytreepublishing.com/shop PROMO CODE: “AEFM” for 10% OFF https://armreg.co.uk  PROMO CODE: "americaneducationfm" for 15% off all books and products.  (I receive no kickbacks).

051325 Scott Adams Show, Trump Pharmaceutical EO, Trump in Riyadh, Democrats in Chaos

Critical minerals are required for the manufacturing of electronics, aerospace equipment, medical devices, and renewable energy technologies, making them essential for a country's economic and national security. These materials have been at the center of China's domestic and foreign policy for many decades, and China's ability to integrate internal industrial policies with foreign trade and investment policies has allowed them to gain dominance in the market. Meanwhile, the US has lagged behind China in terms of both access to and processing technology of critical minerals. The country has been heavily dependent on China for its critical minerals and struggles to find an alternative supplier.China's announcement to impose export restrictions on seven rare earth elements on April 4th has opened many conversations surrounding critical minerals, especially regarding the US and its supply chain vulnerabilities. What has China done to achieve their global dominance in the critical minerals sector, and what can the US do to address the overdependence issue they are facing today? To answer these questions and more, host Bonnie Glaser is joined by Gracelin Baskaran, the director of the Critical Minerals Security Program at the Center for Strategic and International Studies. She is a mining economist whose area of expertise is critical minerals and trade. Timestamps[00:00] Start[02:13] US Dependencies on Rare Earths and Critical Minerals[03:51] Sourcing from Latin America, Africa, and Asia[06:28] Environmental Harm from Mining and Processing[08:11] Deliberate Suppression of the Price of Rare Earths in the Market[11:06] Chinese Exports Restrictions on Seven Rare Earth Elements[14:08] US Administrations' Approaches to Critical Minerals Vulnerability[20:02] 2010 Fishing Boat Accident and Japan's Response [24:00] What might China do moving forward? [27:42] Timeframe for the US to Catch Up to China

- Broadcast News Introduction and Upcoming Segments (0:00) - AI Advancements and Their Impact on Jobs (0:45) - Breaking News: Trump-China Trade Deal and Its Implications (2:46) - Pakistan-India Cyber War and Its Potential Escalation (9:55) - Power Grid Vulnerabilities and Preparedness (13:36) - Crypto Wallets and the Importance of Self-Custody (19:04) - AI Capabilities and Their Implications for Human Jobs (25:14) - The Role of Enoch AI in Empowering Users (59:30) - The War on Human Cognition and Its Vectors (1:05:29) - Strategies for Protecting Cognitive Function (1:21:34) - Chemotherapy and Cognitive Impairment (1:21:56) - Natural Light and Sun Exposure (1:25:06) - Media and Information Warfare (1:30:33) - Societal and Behavioral Factors (1:33:37) - Defending Against Environmental Toxins (1:41:05) - Nutritional and Dietary Factors (1:47:00) - Pharmaceutical and Medical Warfare (1:49:22) - EMF Exposure and Technological Risks (1:59:51) - Information Warfare and Censorship (2:02:12) - Societal and Behavioral Factors (2:11:11) - Zionist and Chinese Strategic Moves in the Middle East (2:25:45) - Trump's Arrogance and Military Presence in Panama (2:26:04) - China's Influence and Economic Strategy in Panama (2:26:21) - Strategic Importance of the Panama Canal (2:52:23) - Strait of Hormuz and Global Energy Supply (3:06:20) - US-China Trade War and Economic Implications (3:14:03) - Anthropological Warfare and Cultural Resilience (3:14:21) - Migration and Demographic Warfare (3:22:15) - Global Economic and Political Dynamics (3:28:51) - Future Strategic Moves and Predictions (3:33:17) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

We kick-off the week with a LIVE press conference from President Trump on a new proposal by the administration to lower drug prices, news on tariffs/China, and a preview of a pivotal case sitting before the Supreme Court. Plus ~ important context to a now viral exchange between the Department of Homeland Security Secretary and Senator Van Hollen (D-MD) over the fate of Kilmar Abrego Garcia.  SUPPORT OUR MISSION: Love nonpartisan news? Want a bigger serving of the serious headlines?  Here's how you can become a SCOOP insider: https://www.scoop.smarthernews.com/get-the-inside-scoop/    Shop our gear!  Instagram: https://www.instagram.com/smarthernews/  Website: https://smarthernews.com/  YouTube Channel: https://www.youtube.com/smarthernews 

Podcast: Government Information Security Podcast (LS 27 · TOP 10% what is this?)Episode: Mature But Vulnerable: Pharmaceutical Sector's Cyber RealityPub date: 2025-05-09Get Podcast Transcript →powered by Listen411 - fast audio-to-text and summarizationPharmaceutical companies typically have more mature cyber programs than other healthcare factions, but these firms also face unique risks involving their large attack surfaces, complex manufacturing, supply chains and sensitive intellectual property, said Joshua Mullen of Booz Allen Hamilton.The podcast and artwork embedded on this page are from GovInfoSecurity.com, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

US stocks eased ahead of the upcoming US-China trade talks, with energy stocks leading gains in the S&P 500 after a rebound in oil prices. Pharmaceutical stocks remained under pressure amid ongoing regulatory concerns, while Tesla shares staged a notable recovery despite prior underperformance. Meanwhile, weaker-than-expected Chinese inflation data created headwinds for AXS miners, adding further uncertainty to the market. Locally, SPI futures suggest a modest gain for the ASX200, while the Aussie dollar holds steady as investors await more details on trade negotiations. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

This podcast was created using Notebook LM.Based on a new study, a recent article highlights the potential of non-pharmaceutical interventions for managing chronic pain, offering alternatives or complements to medication. 

Gemma started her career studying Mechanical Engineering at Cardiff University. She quickly discovered the world of Continuous Improvement and spent 20 years working to improve processes and systems within various manufacturing industries including Automotive, Pharmaceutical, Dairy, Cosmetics & Toiletries, Food, and Medical Devices. She has been a CI Manager numerous times and an Operations Manager running a factory of over 500 people.Gemma is hugely passionate about Improvement and developing people and processes. She gets such a kick out of coaching and facilitating, especially when she sees the lightbulb switch on in someone's head – when they solve a problem; when they realize they have the power to change; or when they get excited about all the improvements they could make.In 2019, Gemma left the world of employment to establish her own business, SPARK Improvement, aiming to switch on as many lightbulbs as possible. Her mission is to help organizations and individuals be the BEST they can be, by helping people SEE, helping people THINK, and helping people CHANGE.Gemma is based in Cheshire in the UK, working globally.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Encouraging physicians to make a diagnosis of irritable bowel syndrome and prescribe medication for it is big business. I'm not saying that medication for IBS is never a good idea or never effective, but I am saying that it is often an overly expedient solution that doesn't usually lead to lasting relief for the simple reason that IBS consists of multiple different conditions. Since there is no one unifying diagnosis of "IBS" there can't be one unifying pharmaceutical solution. We'd love to hear from you - send us a text!Thank you for being a part of our community! For the latest in digestive wellness go to https://gutbliss.com and follow us on https://www.instagram.com/gutbliss/ for more gut health info. Dr. Robynne Chutkan

We take a deep dive into the lesser-known industry of “pharmacy benefits managers” (PBMs) which are parasitical companies that sit in the middle of the incredibly consolidated and vertically integrated market of pharmaceuticals hospitals insurers pharmacy benefits managers pharmacies. Through the simple administrative business of making lists of drugs and networks of pharmacies, PBMs have managed to carve out a multi-billion dollar rent-seeking industry premised on controlling (and jacking up) how much drugs cost and where you can get them—and extracting as much money as possible from people who need those drugs. ••• Timeline of FTC lawsuit against PBMs and relevant documents: https://www.ftc.gov/legal-library/browse/cases-proceedings/221-0114-caremark-rx-zinc-health-services-et-al-matter-insulin ••• Concurring Statement of Commissioner Andrew N. Ferguson https://www.ftc.gov/system/files/ftc_gov/pdf/Ferguson-Statement-Pharmacy-Benefit-Managers-Report.pdf ••• Market Power and Inequality: The Antitrust Counterrevolution and Its Discontents | Lina Khan and Sandeep Vaheesan https://scholarship.law.columbia.edu/faculty_scholarship/2790/ ••• Inside the Mafia of Pharma Pricing | Matt Stoller https://www.thebignewsletter.com/p/inside-the-mafia-of-pharma-pricing ••• A brief look at current debates about pharmacy benefit managers https://www.brookings.edu/articles/a-brief-look-at-current-debates-about-pharmacy-benefit-managers/ Standing Plugs: ••• Order Jathan's new book: https://www.ucpress.edu/book/9780520398078/the-mechanic-and-the-luddite ••• Subscribe to Ed's substack: https://substack.com/@thetechbubble ••• Subscribe to TMK on patreon for premium episodes: https://www.patreon.com/thismachinekills Hosted by Jathan Sadowski (bsky.app/profile/jathansadowski.com) and Edward Ongweso Jr. (www.x.com/bigblackjacobin). Production / Music by Jereme Brown (bsky.app/profile/jebr.bsky.social)

When Luke Rosen's daughter was diagnosed with KIF1A—a rare, progressive neurological disorder—he didn't wait for answers. He and his wife built a community, launched a nonprofit, and became a driving force in rare disease research. In this episode, Luke shares how patient-led science accelerates treatments and reshapes what's possible for families like his. Show Notes  Sounds of Science - N=1 Episode Charles River | Rare Disease Charles River | Rare Disease for Drug Discovery Charles River | ASO Screening Services Personalized ASO Provides Improvement for a Girl with KAND< an Ultra-rare Disease SCA3: A Family Affair Susannah's Superhero Story 

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novartis recently acquired Regulus for $1.7 billion, signaling a trend of increased M&A activity in the pharmaceutical industry. Many companies have hinted at upcoming deals during recent earnings calls, which is seen as a positive sign for the biopharma ecosystem amidst challenges like tariffs and potential drug pricing pressures. GSK remains optimistic about M&A opportunities despite the threat of tariffs, with CEO Emma Walmsley emphasizing a cautious and disciplined approach to dealmaking. Trilink Biotechnologies has introduced custom sets of mRNA for screening studies, offering flexibility and scalability for research needs. The AACR 2025 conference featured promising data from Marengo and Briacell, while Pfizer CEO Albert Bourla has been lobbying against pharmaceutical industry tariffs proposed by President Trump. Overall, the industry is seeing a mix of challenges and opportunities, with companies navigating trade tensions and economic uncertainties while also pursuing strategic growth through acquisitions and innovative research initiatives.Pharmaceutical companies are navigating political uncertainties, particularly in relation to tariffs and dealmaking with China. Major companies are investing billions in US manufacturing to avoid tariffs threatened by President Trump. Despite lobbying efforts, Trump has expressed national security concerns regarding the pharmaceutical industry. CEO-to-employee pay gaps in the industry remain significant. Novartis, GSK, and AstraZeneca are facing challenges and making strategic shifts in response to political and market conditions. Tariff uncertainty is impacting Q1 earnings, with companies like Merck taking significant financial hits. Despite these challenges, the industry remains active with mergers and acquisitions. Upcoming events and job opportunities in the biopharma sector are highlighted.

Listen in as our expert panel discusses medications for management of opioid use disorder. They'll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone.Special guest:Tyler J. Varisco, PharmD, PhDUniversity of Houston College of Pharmacy Assistant Professor, Department of Pharmaceutical Health Outcomes and PolicyAssistant Director, The PREMIER CenterYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Associate Professor of Family Medicine for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program at the University of South Carolina School of Medicine, GreenvilleCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Varisco reports a financial relationship [cardiology, inflammatory bowel disease] with HEALIX Infusion Therapy (research consultant).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in March 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Management of Opioid Use DisorderChart: Treatment of Opioid WithdrawalFAQ: Treatment of Acute Pain in Opioid Use DisorderFAQ: Meds for Opioid OverdoseSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

A new US Pharmaceutical firm has taken up residence in the Shannon Airport Business Park. North Carolina company, Frontier Scientific Solutions has chosen Shannon as its gateway to Europe, where it will avail of temperature-controlled storage for the distribution of life-science goods. Shannon Airport Group also recorded revenues of €73m last year and pre-tax profits of €18m according to its 2024 report. Shannon Airport Group CEO Mary Considine says they're expecting further success.

IrishJobs has published the results of its Jobs Index for Q1 2025, revealing a cautious approach to hiring among firms in the Science and IT sectors ahead of the US Presidential Administration's 'Liberation Day' tariffs announcement. The total number of quarterly job vacancies increased by 5% reflecting the continued strength of the Irish economy and labour market. With close to record low levels of unemployment and moderate domestic growth, the Irish economy is in a strong position to navigate the economic volatility ahead. This economic uncertainty is set to become the new normal over the coming months due to the potential introduction of trade barriers and the emergence of a more protectionist trading environment. The uncertainty created by this shifting trading environment is already starting to impact hiring sentiment in some internationally traded sectors. There has been no change in quarterly job vacancies in either the Science or IT sector according to the Q1 Jobs Index, indicating these sectors have adopted a "wait and see" approach to hiring. The Science sector is composed of a wide range of Pharmaceutical and Life Sciences multinationals which are exposed to potential sector specific trade tariffs. This cautious hiring sentiment is also evident in the IT sector, which could be impacted by retaliatory measures levied by the EU on digital service providers. Consumer-driven sectors associated with the domestic economy, which are less directly impacted by the global trading environment experienced quarterly vacancy growth. Retail (6%), Sport and Fitness (9%), and Sales (28%) all posted strong quarterly vacancy growth. Sectoral trends The Catering sector (11%), which includes jobs in hospitality, accounted for the largest number of vacancies over the past three months. Health (7%), Sales (7%), Management (7%), and Customer Services (6%) completed the top five sectors that made up the largest number of vacancies. Consolidating a trend that emerged in Q3 2024, the Construction sector (5%) contributed marginally more job vacancies than the IT Sector (4.9%). Another property-related sector, Engineering, generated a similar proportion of job vacancies (4.6%) as the IT sector. This continues a broader trend of an uptick in construction and property related job vacancies over the course of 2024. Regional activity Findings from the Index show that several counties with large cities experienced moderate to strong increases in job vacancies, including Galway (22%), Waterford (13%), and Dublin (3%). In county Galway, Staff Nurses, Production Operators & Engineers, and Customer & Sales Assistants were some of the most in-demand roles over the quarter. Engineers, Maintenance Technicians, and Staff Nurses were among the most in-demand role in Waterford in the first three months of 2025. Hybrid and remote working trends Findings from the Index show that the proportion of hybrid working vacancies as a share of total vacancies has increased to 11% over the past three months. Over the past three quarters, the number of hybrid working vacancies as a share of total vacancies has remained stable or slightly increased. These findings suggest that hybrid working will continue to be a substantial feature of the Irish labour market over the coming months. In contrast, the share of fully remote vacancies as a proportion of overall vacancies remains relatively low at 2.4%. While there was a slight increase (0.1%) in the share of fully remote job vacancies over the past three months, their availability remains down 80.6% from the peak recorded in 2021. These trends indicate that fully remote work vacancies will likely remain stable at a relatively low level into the future. Commenting on the release of the index, Julius Probst, European Labour Market Economist at The Stepstone Group and IrishJobs, said: "The Irish labour market continues to perform well, with an exceptionally low unemployment rate of 4% paired with employment gains of about 70,0...

Ricky Varandas of The Ripple Effect Podcast joins the NDS crew for a mind-expanding conversation that goes everywhere the mainstream won't: government experiments, spiritual warfare, big pharma psy-ops, vaccine propaganda, mental health manipulation, and the death of expert authority.From the haunted legacy of Dr. Brzezinski's cancer research to the prophetic insight of Revelation 18:23 and its connection to modern “pharmakia,” Ricky takes us through the trenches of censorship, cognitive warfare, and systemic deception.Also featuring spicy side tangents on Joe Rogan's slow red pill journey, the weaponized medical industry, Jesse Ventura's bizarre COVID U-turn, and how psychedelics, plant medicine, and even dog psychology reveal the rot at the core of the system.Is the mental health crisis a design flaw—or a design feature? Are Big Pharma's pills just the new black magic? And are we being chemically zombified for easier spiritual possession?This one goes deep.Follow Ricky: TheRippleEffectPodcast.com☠️ NEPHILIM DEATH SQUAD   Skip the ads. Get early access. Tap into the hive mind of dangerous RTRDs in our private Telegram channel — only on Patreon:

AI is transforming job search, recruiting and hiring practices. Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group. Steve is an Executive Recruiter specializing in technology for the Pharmaceutical and Biotech Industry. In this episode Steve shares his insights on how AI is transforming the hiring process.

Starting a recruitment business at 25 with just three years of experience takes serious courage. Haseena Mooncey did exactly that – and she's built something special.On this week's episode of The RAG Podcast, I'm joined by Haseena Mooncey, co-founder of CHR Life Sciences, a modern boutique recruitment firm focused on niche roles across the UK, Ireland, and Europe.Haseena launched the business with a former boss as her co-founder, stepping into entrepreneurship with limited experience but a clear mindset and strong values. Her story is rare, especially as a young woman in recruitment. And it's incredibly inspiring.In this episode, we discuss:What pushed her to take the leap from employee to business ownerThe early challenges of launching with limited experienceThe mindset needed to grow a global contract recruitment businessBalancing a modern outlook with traditional values in how she builds her teamIf you're in your 20s and thinking about starting your own business - or you're just looking for a story that proves age and experience don't define success, this episode is one to tune into.Watch the full conversation live on my LinkedIn this Wednesday at 12 pm or search The RAG wherever you get your podcasts!Chapters00:00 Introduction to Haseena Mooncey and CHR Life Sciences03:00 The journey of starting a business at 2506:03 Navigating early challenges and building a network09:05 The decision to transition from employee to entrepreneur12:05 Establishing CHR Life Sciences and initial struggles14:56 First deals and market expansion18:11 Building a business from the ground up20:54 Reflections on growth and future aspirations22:00 Building relationships in recruitment24:32 Navigating market changes and opportunities26:06 The challenges of remote work and team dynamics28:06 The importance of hiring and team growth30:20 Learning from experience: hiring strategies32:32 The impact of market fluctuations on business36:52 Managing stress and maintaining team morale44:54 Building a values-driven recruitment company48:13 The role of AI in recruitment50:22 Pharmaceutical industry insights52:31 Navigating the future of work55:23 Life goals and work-life balance01:00:13 The importance of relationships in recruitmentes to try and retain as much as possible? And how much is still getting lost along the way? Traditional CRM systems weren't built for the type of recruitment business you're running right now. They were built to rely on the structured, tagged, categorised, and formal data you could feed it. Manual processes that needed you to input specific information, based on specific questions and answers. But what about all the other conversations you're having every single day? Atlas isn't an ATS or a CRM. It's an Intelligent Business Platform that helps you perform 10X better than you could on your own. How? By removing all your low value tasks, acting as your perfect memory, and providing highly relevant recommendations to impact your performance. Learn more about the power of Atlas – and take advantage of the exclusive offer for The RAG listeners – by visiting https://recruitwithatlas.com/therag/ __________________________________________Episode Sponsor: HoxoReady to find 25+ warm leads within seven days on LinkedIn?As a recruiter, most of the working day is spent...

On this episode of The Medical Alley Podcast, we have a conversation with Courtney Jones, Director of Commercial Development at Nu-Tek BioSciences.As the only completely animal-free peptone manufacturing site in the United States, Nu-Tek BioSciences is paving the way for sustainable and effective drug development. Courtney dives into the work Nu-Tek BioSciences is doing, its new manufacturing facility in Austin, MN, and the future of innovation in the biotech space.Send us a message! Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.

Marijuana has never been more popular in America and many believe there could be opportunities to utilize the drug for pharmaceutical purposes. So what's the hold up?Ahead of 4/20, Managing Editor Jack O'Brien talks with MMJ International Holdings CEO Duane Boise about growing pharmaceutical cannabis and what medical marketers need to know about the state of the legal cannabis market.For the Trends segment, Reporter Heerea Rikhraj unpacks Pfizer's decision to scrap its GLP-1 receptor after a patient injury and Pharma Editor Lecia Bushak details why Noom launched a full-page ad in The Wall Street Journal advocating for policy changes regarding compounded GLP-1s.We wrap up with an analysis of HHS Secretary Robert F. Kennedy Jr.'s claim that the department will determine if there's a link between autism and vaccines by September. Music by Sixième Son Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Pharmaceutical companies are calling for 'radical policy change' from the European Union in order to limit a potential 'exodus' of future investment in Ireland and other EU member states.Ian Guider, columnist with the Business Post, joins The Last Word to discuss the warning issued by pharma executives to European Commission president Ursula von der Leyen and more of the latest business news.Catch the full chat by pressing the 'Play' button on this page!

Plus, South Korea says it's preparing roughly $23 billion in government support for the chip sector amid tariff uncertainty. And Netflix aims for a $1trillion market capitalization. Luke Vargas hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Are we on the brink of a major shift in research? In this episode of Sounds of Science, Charles River experts challenge traditional approaches, exploring cutting-edge innovations that enhance animal welfare while driving scientific breakthroughs.   From revolutionary non-animal testing methods to advanced behavioral management strategies, we uncover how ethical care leads to better data and faster drug discovery. Tune in to discover how science, compassion, and innovation are shaping the next era of drug development.Show Notes Animals in Research | 3Rs Alternative Methods Advancement Project CHARTER Program for Lab Animal Welfare Advancing Responsible Science 

On this week's episode of The Debrief Weekly Report, Kenna and Steph, along with their feline producer, Beemo the Cat, run far far far far away from the "psycho salmon" that seem to be appearing due to pharmaceutical pollution in waterways. Next they play with some 3D holograms that have becoming interactive, and taste the latest research into 'digital flavour." Every Tuesday, join hosts Stephanie Gerk, Kenna Hughes-Castleberry, and MJ Banias as they round up the latest science and tech stories from the pages of The Debrief. From far-future technology to space travel to strange physics that alters our perception of the universe, The Debrief Weekly Report is meant for the dreamers who love the science and technology of the future. Follow the Debrief on X: https://twitter.com/Debriefmedia Follow Stephanie Gerk on X: https://twitter.com/stephgerk Follow Kenna Hughes-Castleberry on X: https://twitter.com/kennaculture Have something to tell us? Email the show at weeklyreport@thedebrief.org

Episode 2630: Vinnie Tortorich speaks to Dr. Anthony Jay and they discuss items from plastics to genetics, misrepresentation in the media, and more. https://vinnietortorich.com/2025/04/from-plastics-to-genetics-dr-anthony-jay-episode-2630 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE -  From Plastics to Genetics Dr. Anthony Jay was first on Fitness Confidential back in 2017. (2:00) His book can be purchased in Vinnie's Book Club: Estrogeneration: How Estrogenics Are Making You Fat, Sick, and Infertile (Chagrin and Tonic Series)   He is a researcher and geneticist and the information he wrote in the book is finally being discussed on a larger scale. BPAs don't always mean less harmful; BPS, phthalates, and other chemicals are substituted and can still be an issue. (5:30) The United States allows materials in products and food that are banned in Europe. (8:00) Pharmaceutical companies don't have to release studies, and what they do release is often cherry-picked data presented to the media. Burning carbs for energy means autophagy is not happening. (18:00) Health and genetics play a part in an individual's response to a virus. (23:30) Dr. Jay is a genetic researcher and consultant who helps people pinpoint possible genetic origins of health issues and helps them make changes based on data. They discuss the progression of COVID-19 and the mandates that came along with it. (31:00) The media and pharmaceutical corporations often use fear-mongering tactics and mishandle information. (40:00) Hope and Possibilities Anthony is hopeful that RFK, Jr. will make improvements in the health system, like getting crap out of infant formula. (47:15) What is Dr. Jay's opinion on raw milk? (51:30) Some people are highly sensitive to dairy and generally need to stay away from all dairy; however, others can have raw dairy and not have an issue. Between raw and pasteurized, Anthony personally prefers raw milk and he sources it from a local dairy that he trusts. Conventional milk can have emulsifiers in it to keep it from separating, but emulsifiers are horrible for your health. Emulsifiers are tasteless detergents that weaken your gut lining. (57:30) 23andMe and DNA testing. (1:00:00) Dr Jay is a genetic consultant who can help you see what health needs you may have. (1:00:00) If you decide to use the services that analyze your DNA, you can often opt out of sharing your information. Dr. Jay can give you health insights consultation based on your genetic data. You can do so by contacting him through his website. If you have used a service like 23andMe, Ancestry, MyHeritage, or SelfDecode, and have access to your raw data file, he will be able to help. More News If you are interested in the NSNG® VIP group, closed for registration, but you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days Of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook is available!  You can go to  You can order it from .  Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day!  Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen.  There's a new NSNG® Foods promo code you can use! The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. https://nsngfoods.com/   PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere:  Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere:  REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere:  FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: 

00:00:00 - Bizarre Manager Tales and Alex Jones Clips Show opens with banter about Joe's intense management style and new gig. A selection of wild Alex Jones clips is played, prompting commentary on his chaotic delivery. Brief update on financial markets and some humorous talk about waffles and economic indicators. 00:10:00 - Trump's Tariffs and Global Trade Drama Trump enacts 125% tariffs on China, sparing other nations temporarily. Discussion on whether the goal is to isolate China or encourage wider global cooperation. Kevin O'Leary's call for 400% tariffs sparks debate about fairness and enforcement. 00:20:00 - China Retaliates and Trade War Escalates China responds with 84% retaliatory tariffs, calling for global unity against Trump. Memes and viral videos mocking American factory jobs are discussed. Hosts defend blue-collar work and examine why jobs were offshored post-NAFTA. 00:30:00 - Political Rage and Brain Circuitry New study links political extremism to specific brain circuits. Hosts joke about future pharmaceuticals to dull political emotions, like a “political Prozac.” Pharmaceutical industry's potential to profit off this condition is debated. 00:40:00 - CE-5 UFO Summoning and Sky Jellyfish Jake Barbour's team claims to psychically summon UFOs using CE-5 protocols. Descriptions of “Class 7” jellyfish-like UFOs that pulse and float intelligently. Mick West's debunking dismissed, with debate on whether these are balloons or something more. 00:50:00 - New Jersey Drone Mystery and FAA Denials Claims of anomalous drone behavior over New Jersey in December 2024. FAA reportedly unaware of or uninvolved in some sightings, raising suspicions. Speculation of government cover-ups and comparisons to historic UAP sightings. 01:00:00 - Restaurant Scammers and Ark Excavation Father and son duo scam over 100 French restaurants using fake card/ID trick. Scheme included pretending cards didn't work and leaving IDs they later replaced. Quick note that another attempt is underway to dig up Noah's Ark. 01:10:00 - Disturbing Teacher Abuse and Funeral Fails Shocking story of a teacher inappropriately involved with a special-needs student, also involving drugs and a murder plot. Shift to humorous but unfortunate funeral accident where pallbearers fall into a grave. Referenced comedy sketch “Coffin Flop” adds levity to an awkward moment. 01:20:00 - Middle-Aged Men Trading Cards in Japan Japanese trading card craze features real-life elderly men as collectible characters. Discussion on creating an American version featuring “Ohio Man” and regional archetypes. Hosts express genuine excitement and support for the quirky collectible concept. 01:30:00 - Urine Revenge and Tech Troubles A man throws bottles of urine at a business that denied him a job interview. Mike vents frustration about TeeSpring withholding merch funds, delaying tech upgrades. Conversation shifts toward moving to a new platform for merchandise fulfillment. 01:40:00 - Pee Tossing Fallout and David Paulides Kickstarter Extended jokes about urine-throwing suspect and weird job interview tactics. Update on David Paulides' successful Kickstarter for a new Missing 411 film. Mike reveals he won't receive his merch funds in time to upgrade his gear due to delays from TeeSpring. 01:50:00 - Mac Mini Upgrades and Japanese Card Economics Mike talks about upgrading his studio with a new Mac Mini to support soundboards. More commentary on Japanese middle-aged trading cards, including pricing, popularity, and potential U.S. parallels. Hosts suggest capitalizing on the trend with an American version featuring local archetypes.   Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research ▀▄▀▄▀ CONTACT LINKS ▀▄▀▄▀ ► Phone: 614-388-9109 ► Skype: ourbigdumbmouth ► Website: http://obdmpod.com ► Twitch: https://www.twitch.tv/obdmpod ► Full Videos at Odysee: https://odysee.com/@obdm:0 ► Twitter: https://twitter.com/obdmpod ► Instagram: obdmpod ► Email: ourbigdumbmouth at gmail ► RSS: http://ourbigdumbmouth.libsyn.com/rss ► iTunes: https://itunes.apple.com/us/podcast/our-big-dumb-mouth/id261189509?mt=2   - Affiliates Links - Jackery:  https://shrsl.com/3cxhf Barebones:  https://bit.ly/3G38773  Buy Tea! Mike's wife makes some good tea: Naked Gardener Teas: https://www.thenakedgardener.us/store Bags Art Store: https://www.redbubble.com/people/BagsDraws/  

China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notice, pouring billions into partnerships and research projects across the country. But can China maintain this momentum — or will political pressure and consumer skepticism slow things down? Skip Montreux and Dez Morgan explore how China's pharmaceutical and biotech sectors are reshaping the global healthcare landscape. They trace the industry's evolution from state-run factories to world-class R&D centers, discuss the surge in foreign investment, and introduce key players like Akeso Biopharma. Along the way, they also unpack some of the challenges that may lie ahead for this fast-growing industry. Their conversation is a great learning resource if you want to build your English listening comprehension skills and expand your business vocabulary. Key points of their discussion include: The difference between pharmaceuticals and biotech — and where they overlap. The rise of Chinese firms like Akeso Biopharma and their potential to rival Western Big Pharma. Key challenges facing the sector, including domestic reputation issues and foreign policy risk. Do you like what you hear? Become a D2B Member today for to access to our -- NEW!!!-- interactive audio scripts, PDF Audio Script Library, Bonus Vocabulary episodes, and D2B Member-only episodes. Visit d2benglish.com/membership for more information. Follow Down to Business English on Apple podcasts, rate the show, and leave a comment. Contact Skip, Dez, and Samantha at downtobusinessenglish@gmail.com Follow Skip & Dez Skip Montreux on Linkedin Skip Montreux on Instagram Skip Montreux on Twitter Skip Montreux on Facebook Dez Morgan on Twitter RSS Feed

Send us a textThis podcast originally ran on October 21, 2023.This week we get down to basics, and basics are exactly what we need in this confusing world right now. This is THE podcast to listen to if you are confused about all things to do with taking hormone therapy.Dr Vikram Sinai Talaulikar is a specialist in reproductive medicine at University College London Hospital's NHS Foundation Trust and an associate professor in Women's Health at the University College London. He graduated in medicine in India in 2003 and completed a postgraduate degree in obstetrics and gynecology in 2007. He is a certified menopause specialist by the British Menopause Society, a menopause trainer and he is constantly educating others on this transition as well, via online webinars, events and through social media. He is also part of the trio who established the Menopause Research Education Fund, alongside medical journalist Fiona Clarke and groundbreaking menopause campaigner Diane Danzebrink.Highlights of our discussion: Hormone therapy (HT) 101WHI: good, bad and what we can learn from it 20 years onEstrogen in the pill vs estrogen in HT All the kinds of estrogen and what they are used for strogen too ethinyl estradiolEstrone, Estriol, Estradiol, and Estetrol.17 beta estradiolGetting to the bottom of body simila, body identical and bioidentical – and why that varies from country to country Pharmaceutical company produced HT vs compounding pharmacy versionsthe big “Catch-22” with compounding pharmacies that keeps their bioidentical hormones out of official recommendationsthe pill, HRT and breast cancer riskwhy problems with the pill don't get flagged and HRT does Evidence over estrogen and breast cancer risk (and randomized trials versus observational data)What's what: progesterone, progestin and progestogens (how they work and which one carries a slight risk for breast cancer)how long you really need to take HRT to see if it's workingwhy HT works for some people and not othersDr Talaulikar's favourite non-hormonal treatmentsWhere to find Dr Talaulikar:X: @VikramSinai Web: Menopause Clinic LondonMenopause Research and Education FundThe Living in Clarity Podcast, with Fish & Coach Do you want to live an awesome life and to also inspire others? Fish is a world...Listen on: Apple Podcasts SpotifyJoin the Hotflash inc perimenoposse: Web: hotflashinc.comNewsletter: Hotflash inc. on SubstackTikTok: @hotflashincInstagram: @hotflashincX: @hotflashinc Episode website: Hotflashinc Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack See hotflashinc.com/privacy-policy for privacy information

The Green Impact Report Quick take: Packaging and sustainability expert Tom shares how AI and smart technology are transforming recycling and landfill diversion efforts in stadiums, universities, and corporate buildings – creating a more engaging path to sustainability for the next generation. Meet Your Fellow Sustainability Champion  Thomas (Tom) Grinnan is a Global executive and consultant who thrives in new markets, leveraging 25+ years in the Pharmaceutical, Life Science & Packaging industries. With a strong background in sustainable packaging innovation, he's now leading DC1 as CEO, where they develop AI-powered solutions to drive recycling and reduce landfill waste. At DC1, Tom is focusing on landfill diversion through innovative technology that makes recycling more accessible, measurable, and engaging for users while providing valuable sustainability metrics for organizations. Tom began his career in strategic planning after studying French and biology at the University of Virginia. His multilingual skills (fluent in French with knowledge of Spanish, Japanese, and German) helped him develop a niche in cross-border market expansion. Throughout his career, Tom has grown businesses by 15%+ annually through strategic innovation and mentoring. Prior to joining DC1 in March 2024, he worked with major corporations like Midwest, Faco, Westrock, and Silgan, where he gained firsthand experience in sustainable manufacturing practices that reuse resources and minimize environmental impact.

Join Dr. John Abramson and Robert Whitaker as they evaluate the trustworthiness of clinical trials and medical data. Understand the importance of reliable data in making informed health decisions. #ClinicalTrials #MedicalData #HealthEvidence

On this episode, associates discuss the Senate Bill 150 - the Affordable Prescriptions for Patients Act of 2023.

In this episode, we share a recast of episode 302 where HeHe chats with Alexandra, the founder of Just The Inserts, to discuss the crucial topic of informed consent in pregnancy and pediatric care. With the current measles outbreak, it's more important than ever for parents and professionals to understand informed consent in the context of vaccines. Alexandra shares her journey in advocating for informed consent, the importance of reading pharmaceutical inserts, and navigating the complexities of the healthcare system. Whether you're an expecting parent or looking to make informed medical decisions for your family, this episode provides invaluable advice and resources. Don't miss Alexandra's tips on how to understand medical options, ensure safety, and feel confident in your healthcare choices. 00:00 Welcome to the Birth Lounge Podcast 00:48 Introducing the Host and Podcast Purpose 11:07 Diving into the Vaccine Debate 13:20 Navigating Medical Decisions and Providers 20:14 Understanding Informed Consent 25:13 The Importance of Reading Medical Inserts 31:40 Resources for Learning About Medical Inserts 34:00 Understanding the Bolded Parts 34:28 Introducing the New Book 35:12 Empowering Medical Decisions 37:04 The Importance of Vaccine Inserts 40:25 Concerns About Adverse Reactions 43:44 Transparency in Medical Information 47:51 State Laws and Medical Freedom 56:46 Resources for Informed Consent Guest Bio: Alexandra is the visionary behind Just the Inserts, a resource dedicated to empowering individuals and families with clear, accessible information about medical choices. With a background steeped in research and a commitment to transparency, Alexandra has become a trusted voice in the informed consent community, helping countless people navigate the complex world of medical information.   BIRTH EDUCATION: Get the free class to help you avoid a c-section and reduce your risk of tearing!    Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience!   Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone! INSTAGRAM: Connect with HeHe on IG: https://www.instagram.com/tranquilitybyhehe/ Connect with Alexandra on IG: https://www.instagram.com/justtheinserts/ LINKS MENTIONED: https://www.justtheinserts.com/ https://www.ncbi.nlm.nih.gov/ Grab Alexandra's book, Well Considered, here: https://justtheinserts.store/

The Rich Zeoli Show- Hour 4: 6:05pm- Stacy Garrity—Pennsylvania Treasurer—joins The Rich Zeoli Show to discuss her new “Money Match” initiative which will automatically return unclaimed properties to thousands of Pennsylvanians. The checks total $1.7 million and are being mailed to an estimated 7,000+ PA residents. 6:30pm- According to what appears to be an erroneous report, Health and Human Services Secretary Robert F. Kennedy Jr. planned to ban pharmaceutical advertisements on television. Rich explains why this would be a bad idea—and likely a First Amendment violation. 6:40pm- On Tuesday, DNI Director Tulsi Gabbard, FBI Director Kash Patel, and CIA Director John Ratcliffe appeared before the Senate Intelligence Committee. During one notable exchange, Sen. Angus King (I-ME) bizarrely scolded Director Gabbard for removing climate change from a list of the most dangerous global threats. 6:50pm- During a Human Rights Campaign event, Congresswoman Jasmine Crockett (D-TX) referred to Texas Governor Greg Abbott as “governor hot wheels.” Gov. Abbott has used a wheelchair since an accident in 1984.

Today's Mystery: A druggist is murdered in front of Danny and the death is tied to a shooting and robbery at a Pharmaceutical plant.Original Radio Broadcast Date: April 28, 1950Originated in HollywoodStars: Larry Thor as Lieutenant Danny Clover, Charles Calvert as Sergeant Gino Tartaglia, Howard McNear, Paul McVey, Clayton Post, Sylvia Syms,Jeanette NolanGet 17% off your purchase of the Fulton Fish Market (I receive a commission)Support the show monthly at https://patreon.greatdetectives.netPatreon Supporter of the Day: Clarissa, Patreon Supporter since March 2024Support the show on a one-time basis at http://support.greatdetectives.net.Mail a donation to: Adam Graham, PO Box 15913, Boise, Idaho 83715Take the listener survey…http://survey.greatdetectives.netGive us a call 208-991-4783Follow us on Instagram at http://instagram.com/greatdetectivesBecome one of ourfriends on Facebook.Follow us on Twitter@radiodetectivesJoin us again tomorrow for another detective drama from the Golden Age of Radio.

Brigham Buhler is a healthcare entrepreneur, founder and CEO of Ways2Well, and co-founder of ReviveRx Pharmacy. American healthcare stands apart from any other system in the world. While some argue it has the potential to be the best, for many, it feels like the worst. Sky-high costs, an overreliance on prescriptions, and systemic inefficiencies suggest something is deeply broken. Why is this the case, and what can be done to fix it? Expect to learn what the number one reason for bankruptcy in America is, what the average state of health is for the average American and how it compares to the rest of the world, why so many American's are on Pharmaceutical drugs, what drugs Americans are taking that are causing the most damage, what is happening with the Food industry's corporate capture of food, how much of an impact RFK can really have on changing the pharmaceutical and food system, the simple changes that can improve American healthcare and much more… Sponsors: See discounts for all the products I use and recommend: https://chriswillx.com/deals Get a Free Sample Pack of all LMNT Flavours with your first purchase at https://drinklmnt.com/modernwisdom Get $350 off the Pod 4 Ultra at https://eightsleep.com/modernwisdom (use code MODERNWISDOM) Get a 20% discount on Nomatic's amazing luggage at https://nomatic.com/modernwisdom Get the best bloodwork analysis in America at https://functionhealth.com/modernwisdom Extra Stuff: Get my free reading list of 100 books to read before you die: https://chriswillx.com/books Try my productivity energy drink Neutonic: https://neutonic.com/modernwisdom Episodes You Might Enjoy: #577 - David Goggins - This Is How To Master Your Life: https://tinyurl.com/43hv6y59 #712 - Dr Jordan Peterson - How To Destroy Your Negative Beliefs: https://tinyurl.com/2rtz7avf #700 - Dr Andrew Huberman - The Secret Tools To Hack Your Brain: https://tinyurl.com/3ccn5vkp - Get In Touch: Instagram: https://www.instagram.com/chriswillx Twitter: https://www.twitter.com/chriswillx YouTube: https://www.youtube.com/modernwisdompodcast Email: https://chriswillx.com/contact - Learn more about your ad choices. Visit megaphone.fm/adchoices